NO990454D0 - Aerosol-materiale - Google Patents

Aerosol-materiale

Info

Publication number
NO990454D0
NO990454D0 NO990454A NO990454A NO990454D0 NO 990454 D0 NO990454 D0 NO 990454D0 NO 990454 A NO990454 A NO 990454A NO 990454 A NO990454 A NO 990454A NO 990454 D0 NO990454 D0 NO 990454D0
Authority
NO
Norway
Prior art keywords
formulation
aerosol material
polar
delivering
surfactant
Prior art date
Application number
NO990454A
Other languages
English (en)
Other versions
NO990454L (no
NO325491B1 (no
Inventor
Fiona Miller
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10797901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO990454(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of NO990454D0 publication Critical patent/NO990454D0/no
Publication of NO990454L publication Critical patent/NO990454L/no
Publication of NO325491B1 publication Critical patent/NO325491B1/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/44—Valves specially adapted therefor; Regulating devices
    • B65D83/52—Valves specially adapted therefor; Regulating devices for metering
    • B65D83/54—Metering valves ; Metering valve assemblies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
NO19990454A 1996-08-01 1999-01-29 Produkt for avgivelse av farmasoytiske aerosolformuleringer NO325491B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616237.5A GB9616237D0 (en) 1996-08-01 1996-08-01 Aerosol formulations
PCT/GB1997/001502 WO1998005302A1 (en) 1996-08-01 1997-06-03 Aerosol formulations

Publications (3)

Publication Number Publication Date
NO990454D0 true NO990454D0 (no) 1999-01-29
NO990454L NO990454L (no) 1999-03-29
NO325491B1 NO325491B1 (no) 2008-05-19

Family

ID=10797901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990454A NO325491B1 (no) 1996-08-01 1999-01-29 Produkt for avgivelse av farmasoytiske aerosolformuleringer

Country Status (14)

Country Link
US (3) US7566445B1 (no)
EP (1) EP0918507B2 (no)
JP (2) JP4794701B2 (no)
AT (1) ATE215359T2 (no)
AU (1) AU721920B2 (no)
CA (1) CA2261879C (no)
DE (1) DE69711637T3 (no)
DK (1) DK0918507T4 (no)
ES (1) ES2175413T5 (no)
GB (1) GB9616237D0 (no)
NO (1) NO325491B1 (no)
NZ (1) NZ333986A (no)
PT (1) PT918507E (no)
WO (1) WO1998005302A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
WO2000023065A2 (de) * 1998-10-17 2000-04-27 Boehringer Ingelheim Pharma Kg Lagerfähiges wirkstoffkonzentrat mit formoterol
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
EP2482797B1 (en) * 2009-09-29 2018-09-12 Glaxo Group Limited Improvements to pressurised metered dose inhalers
US9401975B2 (en) 2010-11-10 2016-07-26 Panasonic Intellectual Property Corporation Of America Terminal and codec mode selection method
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EA201790832A1 (ru) 2014-10-16 2017-09-29 Тева Брэндид Фармасьютикал Продактс Ар Энд Ди, Инк. Ингалируемый состав
US10563361B2 (en) 2016-01-12 2020-02-18 Ch3 Solutions, Llc System and method for customizing a playing field

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US261539A (en) * 1882-07-25 Sap-pail cover and holder
BE555319A (no) * 1956-03-21 1900-01-01
BE556587A (no) 1957-01-31 1957-04-11
AT215359B (de) 1958-04-05 1961-05-25 Fleissner Gmbh Siebtrommeltrockner für Fasermaterial
GB8501015D0 (en) 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
AU587472B2 (en) 1985-05-22 1989-08-17 Liposome Technology, Inc. Liposome inhalation method and system
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
WO1991014422A1 (en) 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
EP0536204B1 (en) 1990-06-27 1994-04-06 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
NZ238749A (en) 1990-06-28 1993-07-27 Glaxo Inc Aerosol inhalation drug formulations with 1,1,1,2-tetrafluoroethane as propellant and a perfluorinated surfactant
AU8055691A (en) 1990-06-29 1992-01-23 Fisons Plc Pressurised aerosol compositions
WO1992002287A1 (en) 1990-08-09 1992-02-20 Stokes, Jack, A. Oil reclaiming device
US5115803A (en) * 1990-08-31 1992-05-26 Minnesota Mining And Manufacturing Company Aerosol actuator providing increased respirable fraction
DE69105212T2 (de) * 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
GB9024365D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
NZ243061A (en) 1991-06-10 1993-09-27 Schering Corp Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
US6503482B1 (en) 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
WO1992022286A1 (en) 1991-06-12 1992-12-23 Minnesota Mining And Manufacturing Company Albuterol sulfate suspension aerosol formulations
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
DE4132176C2 (de) 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
ATE171865T1 (de) 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
DE69218455T2 (de) † 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
US5376359A (en) 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
JPH0780069A (ja) 1993-09-13 1995-03-28 Otsuka Pharmaceut Co Ltd プロカテロールを含有するエアゾール製剤
DK0735884T3 (da) † 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
US5635159A (en) 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
KR19980703850A (ko) 1995-04-14 1998-12-05 그레이엄브레레톤 베클로메타손 디프로피오네이트용 계량 흡입기
GB9610341D0 (en) 1996-05-17 1996-07-24 Andaris Ltd Formulation for inhalation
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
IES80485B2 (en) 1996-12-04 1998-08-12 Bioglan Ireland R & D Ltd Pharmaceutical compositions and devices for their administration
AU718967B2 (en) 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
GB2332372B (en) 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
ES2141049B1 (es) 1998-03-11 2000-10-16 Aldo Union S A Lab Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
MA26621A1 (fr) 1998-04-18 2004-12-20 Glaxo Group Ltd Composition pour aerosols pharmaceutiques
PT1087750E (pt) 1998-06-18 2004-02-27 Boehringer Ingelheim Pharma Formulacoes farmaceuticas para aerossois com duas ou mais substancias activas
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
WO2000006121A1 (de) 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
WO2000007567A1 (de) 1998-08-04 2000-02-17 Jago Research Ag Medizinische aerosolformulierungen
US6136294C1 (en) 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
JP2002536319A (ja) 1999-02-05 2002-10-29 シプラ・リミテッド 局所用スプレー
GB9903759D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19924098A1 (de) 1999-05-26 2000-12-07 Boehringer Ingelheim Pharma Edelstahlkanister für treibgasbetriebene Dosieraerosole
CN1144582C (zh) 2000-11-28 2004-04-07 中国药科大学 治疗呼吸系统疾病的无氟里昂药用气雾剂
WO2003072777A1 (fr) 2002-02-27 2003-09-04 Yasumitsu Nagao Animal dont l'embryon est modifie et procede de construction de cet animal
JP4527949B2 (ja) 2003-06-24 2010-08-18 ニプロパッチ株式会社 粘着テープ

Also Published As

Publication number Publication date
EP0918507A1 (en) 1999-06-02
GB9616237D0 (en) 1996-09-11
US9650203B2 (en) 2017-05-16
NO990454L (no) 1999-03-29
PT918507E (pt) 2002-09-30
WO1998005302A1 (en) 1998-02-12
NO325491B1 (no) 2008-05-19
NZ333986A (en) 1999-05-28
DE69711637T3 (de) 2016-04-28
JP2011173910A (ja) 2011-09-08
AU3038197A (en) 1998-02-25
EP0918507B2 (en) 2015-12-09
DE69711637D1 (de) 2002-05-08
DK0918507T3 (da) 2002-07-29
US7566445B1 (en) 2009-07-28
JP4794701B2 (ja) 2011-10-19
US20140326759A1 (en) 2014-11-06
US20090246148A1 (en) 2009-10-01
AU721920B2 (en) 2000-07-20
CA2261879C (en) 2006-10-03
EP0918507B1 (en) 2002-04-03
ATE215359T2 (de) 2002-04-15
CA2261879A1 (en) 1998-02-12
DE69711637T2 (de) 2002-11-28
JP2000515536A (ja) 2000-11-21
DK0918507T4 (en) 2016-03-14
US8834849B2 (en) 2014-09-16
ES2175413T3 (es) 2002-11-16
ES2175413T5 (es) 2016-05-26

Similar Documents

Publication Publication Date Title
NO990454D0 (no) Aerosol-materiale
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
BG102689A (en) Pharmaceutical aerosol composition
NO972781L (no) Aerosolformuleringer av peptider og proteiner
ES2079210T3 (es) Formulacion farmaceutica de aerosol.
DE69231992D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
GEP20002140B (en) Pharmaceutical Aerosol Composition
MY118151A (en) Pharmaceutical formulations containing voriconazole.
DK1123120T3 (da) Medicinsk aerosolformulering
ES2151476T3 (es) Formulaciones de farmacos en aerosol.
ES2189410T3 (es) Formulacion farmaceutica en aerosol.
PT1037604E (pt) Composicoes farmaceuticas de aerossol
GB2354007B (en) Pharmaceutical formulation of fluticasone propionate
WO1998008517A3 (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
NO980858L (no) Farmas÷ytiske preparater og anordninger for administrering derav
MX9707238A (es) Formulaciones en aerosol de butixocort.

Legal Events

Date Code Title Description
MK1K Patent expired